Skip to content

The efficacy evaluation of different rehabilitation intervention timing for acute exacerbation of chronic obstructive pulmonary disease

The efficacy evaluation of different rehabilitation intervention timing for acute exacerbation of chronic obstructive pulmonary disease

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300078189
Enrollment
Unknown
Registered
2023-11-30
Start date
2023-04-19
Completion date
Unknown
Last updated
2023-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

AECOPD

Interventions

Pulmonary rehabilitation group ?:After admission, routine treatment and health education will begin immediately. Within 2 days of admission, pursed lip breathing, abdominal breathing, and/or Pulmonary
Pulmonary rehabilitation group ?:After admission, routine treatment and health education will begin immediately. On the fifth day after admission, pursed lip breathing, abdominal breathing, and/or Pul
Pulmonary rehabilitation group ?:After admission, routine treatment and health education will begin immediately. After meeting the discharge criteria during hospitalization, pursed lip breathing, abdo
Control group:Routine treatment and health education after asmission

Sponsors

The First Affiliated Hospital of Henan University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Clear diagnosis of AECOPD; (2) Age between 40 and 80 years; (3) Stable condition within 1-2 days of hospitalization, capable of undergoing rehabilitation training; (4) Willing to participate in rehabilitation training and sign an informed consent form.

Exclusion criteria

Exclusion criteria: (1) Patients with severe cognitive impairment, dementia, or various psychiatric disorders; (2) Patients with bone and joint diseases affecting movement such as severe arthritis; (3) Patients with neuromuscular disorders causing difficulty in activities; (4) Patients with bronchiectasis, pulmonary fibrosis, or asthma; (5) Patients with deep vein thrombosis of the lower extremities; (6) Patients with stable angina pectoris or acute myocardial infarction; (7) Patients who have been bedridden for long periods due to various reasons; (8) Patients currently participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
6-min walking distance;COPD assessment test;

Secondary

MeasureTime frame
the Multidimensional Fatigue Index-20;Borg score;30s Sit-to-Stand Test;Saint George Respiratory Questionnaire;COPD - Patient Reported Outcomes;modified Efficacy Satisfaction Questionnaire - COPD;the length of hospital stay;

Countries

China

Contacts

Public ContactZhang Hailong

The First Affiliated Hospital of Henan University of Chinese Medicine

zhanghailong6@126.com+86 136 4371 8969

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026